Literature DB >> 2458038

Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon.

C E Furlong1, R J Richter, S L Seidel, A G Motulsky.   

Abstract

Plasma paraoxonase is a polymorphic enzyme that hydrolyzes paraoxon, the neurotoxic, active metabolite of the insecticide parathion. This enzyme is specified by at least two alleles with frequencies of about .7 and .3 among Caucasoid populations. A specific assay was developed that measured the activity of human plasma paraoxonase without interference from serum albumin which contributes significantly to the hydrolytic breakdown of paraoxon at the high pH values used in many previous assays. There was an 11-fold variation in paraoxonase activities, and the population distribution was at least bimodal. However, this specific assay did not improve the discrimination between the three genetic classes: (1) homozygotes for the low-activity allele, (2) heterozygotes, and (3) homozygotes for the high-activity allele. Chlorpyrifos oxon--the neurotoxic metabolite of the organophosphorus insecticide chlorpyrifos (Dursban)--was hydrolyzed by the same plasma fraction that hydrolyzed paraoxon. There was only four- to fivefold variability in enzyme activity, and the population distribution was unimodal. Homozygotes for low paraoxonase activity ranged over almost the entire spectrum of chlorpyrifos oxonase activity. Possible differences in susceptibility to chlorpyrifos toxicity therefore are unlikely to be predicted by the paraoxonase genotype alone. The ratio of paraoxonase over that of chlorpyrifos oxonase provided an excellent method for genetic typing of the paraoxonase polymorphism, as did the substitution of phenylacetate for chlorpyrifos as the substrate.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458038      PMCID: PMC1715392     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers.

Authors:  W KALOW; N STARON
Journal:  Can J Biochem Physiol       Date:  1957-12

2.  Genetic polymorphism and interethnic variability of plasma paroxonase activity.

Authors:  J R Playfer; L C Eze; M F Bullen; D A Evans
Journal:  J Med Genet       Date:  1976-10       Impact factor: 6.318

3.  Organophosphate splitting serum enzymes in different mammals.

Authors:  R Zech; K Zürcher
Journal:  Comp Biochem Physiol B       Date:  1974-07-15

4.  Effects of lipid removal on the molecular size and kinetic properties of bovine plasma arylesterase.

Authors:  B J Kitchen; C J Masters; D J Winzor
Journal:  Biochem J       Date:  1973-09       Impact factor: 3.857

5.  [Enzymatic hydrolysis of diethyl-p-nitrophenylphosphate (E 600) by human serum].

Authors:  K Krisch
Journal:  Z Klin Chem Klin Biochem       Date:  1968-01

6.  Genetics of paraoxonase.

Authors:  H Eiberg; J Mohr
Journal:  Ann Hum Genet       Date:  1981-10       Impact factor: 1.670

7.  The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts.

Authors:  H W Eckerson; J Romson; C Wyte; B N La Du
Journal:  Am J Hum Genet       Date:  1983-03       Impact factor: 11.025

8.  Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies.

Authors:  R F Mueller; S Hornung; C E Furlong; J Anderson; E R Giblett; A G Motulsky
Journal:  Am J Hum Genet       Date:  1983-05       Impact factor: 11.025

9.  Distribution of serum paraoxon hydrolyzing activities in a Canadian population.

Authors:  G Carro-Ciampi; D Kadar; W Kalow
Journal:  Can J Physiol Pharmacol       Date:  1981-08       Impact factor: 2.273

10.  On the genetics of the human serum paraoxonase (EC 3.1.1.2).

Authors:  M Geldmacher-v Mallinckrodt; G Hommel; J Dumbach
Journal:  Hum Genet       Date:  1979-09       Impact factor: 4.132

View more
  36 in total

1.  Serum arylesterase and paraoxonase activity in patients with chronic hepatitis.

Authors:  Suleyman Sirri Kilic; Suleyman Aydin; Nermin Kilic; Fazilet Erman; Suna Aydin; Ilhami Celik
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 2.  Erythrocyte acetylcholinesterase as biomarker of pesticide exposure: new and forgotten insights.

Authors:  Caio R D Assis; Amanda G Linhares; Mariana P Cabrera; Vagne M Oliveira; Kaline C C Silva; Marina Marcuschi; Elba V M Maciel Carvalho; Ranilson S Bezerra; Luiz B Carvalho
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-24       Impact factor: 4.223

Review 3.  Organophosphate neurotoxicity to the voluntary motor system on the trail of environment-caused amyotrophic lateral sclerosis: the known, the misknown, and the unknown.

Authors:  Samantha J Merwin; Teresa Obis; Yanelli Nunez; Diane B Re
Journal:  Arch Toxicol       Date:  2017-01-09       Impact factor: 5.153

Review 4.  The human serum paraoxonase/arylesterase polymorphism.

Authors:  B N La Du
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

5.  Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.

Authors:  Christina Charles-Schoeman; Yuen Yin Lee; Victor Grijalva; Sogol Amjadi; John FitzGerald; Veena K Ranganath; Mihaela Taylor; Maureen McMahon; Harold E Paulus; Srinivasa T Reddy
Journal:  Ann Rheum Dis       Date:  2012-01-20       Impact factor: 19.103

6.  Relationship between the paraoxonase (PON1) L55M and Q192R polymorphisms and obesity in a Mexican population: a pilot study.

Authors:  Maria Fernanda Martínez-Salazar; Damianys Almenares-López; Sara García-Jiménez; Miguel Angel Sánchez-Alemán; Alina Juantorena-Ugás; Camilo Ríos; Antonio Monroy-Noyola
Journal:  Genes Nutr       Date:  2011-03-25       Impact factor: 5.523

7.  Protective Effects of an Oxovanadium(IV) Complex with N2O2 Chelating Thiosemicarbazone on Small Intestine Injury of STZ-Diabetic Rats.

Authors:  Sevim Tunali; Selda Gezginci-Oktayoglu; Sehnaz Bolkent; Ediz Coskun; Tulay Bal-Demirci; Bahri Ulkuseven; Refiye Yanardag
Journal:  Biol Trace Elem Res       Date:  2020-07-09       Impact factor: 3.738

8.  Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.

Authors:  Ayşe Yeşim Göçmen; Saadet Gümüşlü; Ender Semiz
Journal:  Clin Cardiol       Date:  2004-07       Impact factor: 2.882

9.  Is elevated serum ceruloplasmin level associated with increased risk of coronary artery disease?

Authors:  Ayşe Yeşim Göçmen; Emel Sahin; Ender Semiz; Saadet Gümuşlü
Journal:  Can J Cardiol       Date:  2008-03       Impact factor: 5.223

10.  Cathepsin B inhibition improves lung injury associated to D-galactosamine/tumor necrosis factor-alpha-induced liver injury in mice.

Authors:  Fusun Oztay; Selda Gezginci-Oktayoglu; Bertan Boran Bayrak; Refiye Yanardag; Sehnaz Bolkent
Journal:  Mol Cell Biochem       Date:  2009-07-22       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.